Track topics on Twitter Track topics that are important to you
The post Cambrex signs $252m agreement to acquire Avista Pharma appeared first on Pharmaceutical Technology.
Original Article: Cambrex signs $252m agreement to acquire Avista PharmaNEXT ARTICLE
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...